6533b7d2fe1ef96bd125f4d1

RESEARCH PRODUCT

Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for the diagnosis of COVID-19 in primary healthcare centers

M MartínezJavier ColominaDixie HuntleyMolla EFelipe BuenoSandrine PoujoisJosep FerrerFernández-fuentes MáDe La Asunción CsDavid NavarroIgnacio TorresLorena ForquéArantxa ValdiviaEliseo Albert

subject

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)business.industryRapid antigen testSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Primary health careMedicinebusinessNuclear medicine

description

AbstractWe evaluated the Panbio™ COVID-19 AG Rapid Test Device (RAD) for the diagnosis of COVID-19 in symptomatic patients attended in primary healthcare centers (n=412). Overall specificity and sensitivity of RAD was 100% and 79.6%, respectively, taking RT-PCR as the reference. SARS-CoV-2 could not be cultured from specimens yielding RT-PCR+/RAD- results.

yearjournalcountryeditionlanguage
2020-10-20
https://doi.org/10.1101/2020.10.16.20213850